new deadly human-to-human-transmissible coronavirus emerges out of China
POSTED BY: 1KIKI
UPDATED: Tuesday, May 5, 2026 22:21
VIEWED: 203741
PAGE 260 of 283
PLEASE NOTE: July 8
Pfizer To Seek Authorization For "Booster" Dose To Protect Against Delta Variant
Tyler Durden's Photo
by Tyler Durden
Thursday, Jul 08, 2021 - 07:20 PM
Hours ago, Dr. Anthony Fauci emphatically defended the efficacy of the three American-made vaccines that have received emergency authorization for use by the FDA. His comments weren't unprompted: reports out of Israel claiming the Pfizer jab is far less effective than advertised have shaken public confidence in the jabs, at a time where President Biden is about to send people knocking on doors to try and encourage more adults (and increasingly, children) to get vaccinated.
It's no secret that a handful of southern and western states are lagging the rest of the country in vaccine rollout. But not long after Dr. Fauci made his comments (which were picked up by all the major newswires) the NYT published a sneak peak at new research showing how the Delta variant bypasses the antibodies created by the vaccines, and prior infection with another strain of the virus.
It's just the latest example of how the authorities don't care about the "science" so much as protecting the narrative that helps Big Pharma sell the most vaccines. And while the vast majority of countries are still struggling with vaccination rates below 1% since they simply can't get the supplies (while unused jabs are piling up across the US) - and Bill Gates doing everything he can to keep it that way - Pfizer and Moderna have apparently spotted an opportunity.
Pfizer and its partner BioNTech announced Thursday evening that they will seek authorization from the FDA for a third "booster" dose of their COVID vaccines that will offer increased protection against the Delta variant (despite the fact that both Pfizer and its rival Moderna repeatedly insisted that its vaccines are still effective against all known variants including Delta), the Hill reports.
In a statement, the company referenced the data out of Israel, where government scientists have estimated the real efficacy of the vaccine vs. Delta is somewhere around 64%, while leaving particularly vulnerable patients at risk of severe illness and death. The booster dose would ideally be given within 6 to 12 months post-vaccination.
"Based on the totality of the data they have to date, Pfizer and BioNTech believe that a third dose may be beneficial within 6 to 12 months following the second dose to maintain highest levels of protection," the companies said.
The company said it's planning to start clinical trials for a reformulated vaccine that's modified to specifically target the Delta variant. However, the company now believes that a booster dose might be a more effective strategy. The news strikes us as surprisingly aggressive, considering the FDA hasn't even approved the first generation of vaccines yet (they were all granted emergency authorizations, and the FDA is still evaluating safety data, which is why we know the mRNA jabs cause rare side effects including heart inflammation in a small n umber of men).
Ultimately, the CDC and FDA will decide whether to recommend a third dose. But they have a pretty strong track record of safeguarding the interests of the Big Pharma companies that produced the vaccines. So, why would they change course now?
https://www.zerohedge.com/markets/pfizer-plans-seek-authorization-boos
ter-dose-protect-against-delta-variant
-----------
Pity would be no more,
If we did not MAKE men poor - William Blake
THUGR posts about Putin so much, he must be in love.
NOTIFY: Y | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
Switching to a sequence of two DIFFERENT vaxs provides superior protection. That makes sense. While vaxs target the spike protein, they use different snippets of that protein.
The solution seems obvious to me.
NOTIFY: N | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
Quote:There's one part of the second article that offers up the idea that even previous infections aren't protective, but NO DATA to support it.
Originally posted by 1KIKI:
Switching to a sequence of two DIFFERENT vaxs provides superior protection. That makes sense. While vaxs target the spike protein, they use different snippets of that protein.
The solution seems obvious to me.
Part of the problem is that nobody knows who was previously infected, and -as far as I can tell- there's no way to figure that out six months after the fact since antibodies fade even if T-cell memory remains.
*****
EVOLUTION WORKS!
I suspect that this will wind up being a lot like "the flu", as vaccine-maker try to predict which strain will become dominant and adjust their vaccines accordingly.
-----------
Pity would be no more,
If we did not MAKE men poor - William Blake
THUGR posts about Putin so much, he must be in love.
NOTIFY: Y | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
I think natural infection isn't exactly the same as vaccination in this case. The active virus does seem to inhibit at least an interferon portion of the immune response. Plus - and I haven't read this anywhere, it's just my thought using hepatitis B as a basis and the development of antibodies to hepatitis B core proteins - when you develop antibodies to a virus, they act against every protein the virus has to offer. What you need to do is to maximize the variety of antibodies to the spike protein, which are 'neutralizing' antibodies.
Different vaxs use somewhat different portions of the spike protein.
Also, different vax technologies can stimulate different arms of the immune system.
Anyway, initial information about the efficacy of using different vaxs looks good, and countries are actively pursuing this, even though information is sparse. Well, it may not be sparse, but I haven't found an efficient selection of search terms to dig it out from everything else.
A few links are found within this article.
https://www.npr.org/sections/health-shots/2021/05/05/993882203/giving-
2-doses-of-different-covid-19-vaccine-could-boost-immune-response
Though, as I've said before, we won't get rid of SARS-CoV-2 anywhere until we get rid of it everywhere. I think it's still within reach. But whether or not we have the global will remains to be seen.
How's your connection coming along?
NOTIFY: N | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
AP-NORC poll: Most unvaccinated Americans don’t want shots
https://apnews.com/article/joe-biden-science-health-government-and-pol
itics-coronavirus-pandemic-36ea18ee3a3397da7edd5b8249f0e477
Should vaccinated people mask up with COVID-19 cases rising?
https://apnews.com/article/lifestyle-health-coronavirus-pandemic-55535
fe86fe5fe525761ac831f97a9f5
NOTIFY: N | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
Quote:
Originally posted by 1KIKI:
... Also, different vax technologies can stimulate different arms of the immune system.
Anyway, initial information about the efficacy of using different vaxs looks good, and countries are actively pursuing this, even though information is sparse. Well, it may not be sparse, but I haven't found an efficient selection of search terms to dig it out from everything else.
A few links are found within this article.
https://www.npr.org/sections/health-shots/2021/05/05/993882203/giving-
2-doses-of-different-covid-19-vaccine-could-boost-immune-response
How's your connection coming along?
FROM THE LINK
Quote:
The natural human response to a virus is to mobilize two distinct arms of the immune system," says Gritstone CEO Andrew Allen. One utilizes antibodies; the other relies on something called CD8 T cells. Unlike antibodies, CD8 T cells don't recognize a virus directly, but they do recognize a cell that has been infected by a virus and they can destroy the infected cell.
Gritstone has developed two different vaccines to activate each arm: a viral vector vaccine and an mRNA vaccine. The viral vector vaccine is very good at stimulating the production of CD8 T cells.The mRNA [vaccine] makes a really good antibody response. And so potentially by combining these, you kind of get the best of both worlds," Allen say
...If it's such a good idea, why isn't it used routinely?
Pulendran speculates there are two main reasons. One has to do with the way new vaccines are approved.
"Regulatory authorities love simplicity," Pulendran says. "The simpler the vaccine regimen, the more palatable they find this to be."
The other reason is that while mix and match may make scientific sense, it doesn't always make business sense.
"For example, if Company A makes one vaccine and Company B makes another vaccine, unless there's some overarching incentive for the two companies to enter into some sort of a marriage, I think either company would in general prefer to go along with their own," Pulendran says.
Quote:
Though, as I've said before, we won't get rid of SARS-CoV-2 anywhere until we get rid of it everywhere. I think it's still within reach. But whether or not we have the global will remains to be seen.
Some nations have burned so many bridges with their own population that near-universal vaccination is unachievable. Other nations' health systems are so dysfunctional that they can't even control polio. Still others are failed states, in a state of war, or ideologically opposed to anything "the west" attempts.
It would take a scary disease like Ebola to get governments to focus.
-----------
Pity would be no more,
If we did not MAKE men poor - William Blake
THUGR posts about Putin so much, he must be in love.
NOTIFY: Y | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
It would take at least a 20% LEGITIMATE death rate for full vaccination to ever be achievable.
Even then, you'd have to threaten a large portion of the world population with death for refusing, to get 100%.
--------------------------------------------------
Vaccinated People: "You need to get muh vaccination shots that don't work because I got muh vaccination shots that don't work and I'm afraid of people that didn't get muh vaccination shots that don't work because muh vaccination shots that don't work don't work."
NOTIFY: Y | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
So I check in on Divoc-91 now and again to see how we're doing, and altho the "new cases" are rising steeply and have been for four weeks, "new deaths" haven't budged and stay resolutely low. It looks like the vaccine is working to protect the vulnerable from death.
"New cases" tho, hasn't even reached an inflection point. KIKI, wanna take bets as to where it peaks out? My guess is 60/day/100,000 (previous peak was about 77-78).
Let's see how close I get.
-----------
Pity would be no more,
If we did not MAKE men poor - William Blake
THUGR posts about Putin so much, he must be in love.
NOTIFY: Y | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
Quote:
Decline In UK COVID Cases Signals Coming "Inflection" For US As Delta Fears Subside
Cases in the UK and EU are dropping rapidly
https://cms.zerohedge.com/s3/files/inline-images/covidchart.jpeg
There is a strong negative correlation in the USA between vaccination and cases (i.e. the higher the percent vaccinated the lower the number of cases) leading to the idea that vaccination is effective at preventing cases, not just deaths
In the UK (and presumably the rest of the world) where vaccination rates are high, even though cases may rise, deaths remain low
By contrast, in Indonesia where vaccination rate is low (10%), people who get sick die more frequently
Quote:
Analysts at Goldman have reached a similar conclusion: while rising cases may lead to more cautious consumer behavior, we ultimately view the economic and medical risks from the delta variant as manageable, given convincing evidence that the vaccines help prevent serious illness.
The implication for the US is pretty clear.
https://www.zerohedge.com/covid-19/decline-uk-covid-cases-signals-comi
ng-inflection-us-delta-fears-subside
-----------
Pity would be no more,
If we did not MAKE men poor - William Blake
THUGR posts about Putin so much, he must be in love.
NOTIFY: Y | REPLY | REPLY WITH QUOTE | PERMALINK | TOP | HOME
